APA (7th ed.) Citation

Walz, J. S., Kanz, L., Nelde, A., Salih, H. R., Kowalewski, D. J., Backert, L., . . . Weide, B. (2018). Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers. Leukemia & Lymphoma, 59(8), 1949. https://doi.org/10.1080/10428194.2017.1403022

Chicago Style (17th ed.) Citation

Walz, Juliane Sarah, et al. "Favorable Immune Signature in CLL Patients, Defined by Antigen-specific T-cell Responses, Might Prevent Second Skin Cancers." Leukemia & Lymphoma 59, no. 8 (2018): 1949. https://doi.org/10.1080/10428194.2017.1403022.

MLA (9th ed.) Citation

Walz, Juliane Sarah, et al. "Favorable Immune Signature in CLL Patients, Defined by Antigen-specific T-cell Responses, Might Prevent Second Skin Cancers." Leukemia & Lymphoma, vol. 59, no. 8, 2018, p. 1949, https://doi.org/10.1080/10428194.2017.1403022.